Table 2.
No. | Gender | Tumour type | Location | Tumour size (cm) | Total dose/fx (Gy/Fx) | History | Follow-up (months) | Toxicity grade | Toxicity | Time to toxicity (months) |
---|---|---|---|---|---|---|---|---|---|---|
1 | M | Mets | LUL | 2·7 | 30/1 | SBRT 60 Gy in 3 fx (LLL) | 41·2 | 3 | Left vocal cord palsy | 14·5 |
2 | M | Mets | Right hilum | 3 | 26/1 | Chemo-radiation (70 Gy in 35 fx, cancer in the base of tongue) | 12·8 | 4 | Bronchopulmonary haemorrhage | 12·6 |
3 | F | NSCLC | LUL | 1·6 | 52·5/5 | Surgery (RUL) | 33·7 | 3 | Pulmonary embolism | 19·1 |
4 | M | NSCLC | RML | 2·3 | 55/5 | Surgery (LUL) | 22·9 | 3 | Pleural effusion | 14·6 |
Abbreviations: Fx, fraction; M, male; F, female; mets, pulmonary oligometastasis; SBRT, stereotactic body radiation therapy; NSCLC, primary non-small cell lung cancer; LUL, left upper lobe; RML, right middle lobe; LLL, left lower lobe; RUL, right upper lobe.